Questions? Visit the CDO Welcome Desk M-F 9am-5pm or email us at askcdo@mit.edu.  |  The Virtual Interview Room is back!  Learn more here.

Bio / Pharma / Healthcare

BioSpace – Frequency Therapeutics Completes $62 Million Series C Financing

Published on July 23, 2019

Frequency Therapeutics, a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases, today announced the closing of a $62.0 million Series C financing. Frequency will use …

By Danielle Grassia Cañas
Danielle Grassia Cañas Senior Associate Director, Recruiting Operations
Send Email
Read more »

Skyhawk Therapeutics nabs Peloton exec and cancer R&D veteran as VP of oncology biology

Published on July 8, 2019

Two months after Merck announced a billion-dollar-plus deal to buy out late-stage cancer biotech Peloton, some of its staffers are finding new homes.

This is good news for RNA startup Skyhawk Therapeutics, which has nabbed Peloton’s former VP of biology,  …

By MIT Sloan CDO
MIT Sloan CDO
Send Email
Read more »

Facebook rolls out new disease prevention mapping tools

Published on July 1, 2019

The company is releasing three types of maps meant to help public health organizations stay ahead of disease outbreaks and guide disaster response: population density maps, movement maps and network coverage maps.

Continue reading on MedCityNews

By MIT Sloan CDO
MIT Sloan CDO
Send Email
Read more »

Sidebar